SpyGlass Pharma, Inc. Common Stock (SGP) Stock Price

SGPStock
$26.60
Market Cap$889.72M
P/E
PEG Ratio
Div yield
Beta1.23

SGP Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-19.11%
Price vs S&P 500 (4W)18.41%
VGM Score67.28

SGP Earnings Surprise History

Q1 26-0.69est. -0.36
Q2 26-0.59est. -0.55

SGP Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.44
4.44
4.44
4.44

Industry Peers — Surgical & Medical Instruments(140)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
SGPSpyGlass Pharma, Inc. Common Stock
B$26.60
SYKStryker CorporationCBC$330.59
MMM3M CompanyCDB$179.37
BSXBoston Scientific Corp.CBD$49.86
BDXBecton, Dickinson and Co.BDB$189.78
MDLNMedline Inc. Class A common stockCDC$35.64
RMDResMed Inc.CBC$236.59
DXCMDexCom, Inc.DBB$89.16
WSTWest Pharmaceutical Services, Inc.DCB$348.48
SOLVSolventum CorporationCCB$91.61
BAXBaxter International Inc.BDB$26.29

About SpyGlass Pharma, Inc. Common Stock

SpyGlass Pharma is a late-stage biopharmaceutical company developing long-acting drug delivery systems for chronic eye conditions. The company is advancing two programs: the BIM-IOL System, which delivers glaucoma treatment during cataract surgery, and the BIM-DRS for glaucoma patients not undergoing surgery. Both programs leverage sustained drug delivery of approved medicines to address unmet treatment needs in ophthalmology.